Business of Medicine
Although some stakeholders are interested in keeping it going, it’s unclear what that would look like and what role, if any, AHRQ would have.
At least eight states have passed laws to expose questionable pricing of prescription drugs, but critics say the measures don’t go far enough.
Lawmakers say too many physicians are excluded from the program under the current rules.
Steady decline in national rate appears to have halted.
Dr. Jeffrey A. Zonder of the Barbara Ann Karmanos Cancer Institute explains why Right to Try falls short of expectations.
From the Journals
A new study looks at the effectiveness of existing expanded access programs in the wake of enacting the Right to Try law.
Unscientific survey by two senators indicates it’s not going to happen.
Solid teamwork among physicians and nurses not only makes for a smoother work environment, it also helps to reduce medical errors and lower the...
Under the “Captain of the Ship” doctrine, physicians may face growing liability risks from their assistants’ negligence.